Encephalitis

Data sharing policy

Page Path

HOME
EDITORIAL POLICY
Data sharing policy

encephalitis encourages data sharing wherever possible, unless this is prevented by ethical, privacy, or confidentiality matters. Authors wishing to do so may deposit their data in a publicly accessible repository and include a link to the DOI within the text of the manuscript.

Clinical Trials: encephalitis accepts the ICMJE Recommendations for data sharing statement policy. Authors may refer to the editorial, “Data Sharing statements for Clinical Trials: A Requirement of the International Committee of Medical Journal Editors,” in the Journal of Korean Medical Science (https://dx.doi.org/10.3346/jkms.2017.32.7.1051).

MOST VIEWED MOST CITED

4,901	Neuroprotective effects of melatonin in neurodegenerative and autoimmune central nervous system diseases
5,557	Posttransplant lymphoproliferative disorder in a kidney transplant recipient: a case of Epstein-Barr virus-positive primary central nervous system lymphoma
3,689	Management of convulsive status epilepticus: recent updates
4,154	Lumbar puncture: considerations, procedure, and complications
7,024	Successful treatment with rituximab for central nervous system vasculitis caused by Epstein-Barr virus-associated lymphoproliferative disorder with immunoglobulin M gammopathy

+more

Cited By 2	Chronic social stress during early development elicits unique behavioral changes in adulthood
Cited By 2	Management of convulsive status epilepticus: recent updates
Cited By 2	Protein biomarkers in multiple sclerosis
Cited By 1	Direct brain involvement of Takayasu arteritis treated with rituximab and infliximab: a case report
Cited By 1	Clinical significance of Epstein-Barr virus polymerase chain reaction in cerebrospinal fluid

+more

Editorial Office: 101, Daehak-ro, Jongno-gu, Seoul 03080, Republic of Korea
Tel: +82-2-2072-0629 Fax: +82-2-765-7920 E-mail: editor@encephalitisjournal.org